| DM | Diabetes Mellitus |
| CVD | Cardiovascular Disease |
| WHO | World Health Organization |
| eNOS | endothelial nitric oxide synthase |
| NO | nitric oxide |
| VCAM-1 | vascular cell adhesion molecule |
| vWF | von Willebrand factor |
| CRP | C-reactive protein |
| TNF | tumor necrosis factor |
| Ang II | angiotensin II |
| PAI-1 | plasminogen activator inhibitor-1 |
| ADMA | asymmetric dimethyl arginine |
| LDL | low-density lipoprotein |
| HDL | high-density lipoprotein |
| VLDL | very low-density lipoprotein |
| NADPH | nicotinamide adenine dinucleotide phosphate oxidase |
| XO | xanthine oxidase |
| GTP | guanosine triphosphate |
| EC | endothelial cell |
| SREBP1 | sterol regulatory element-binding protein 1 |
| CD | cluster of differentiation |
| PKC | protein kinase C |
| HbA1c | glycated hemoglobin |
| AGEs | advanced glycation end products |
| RAGE | AGE receptor |
| GP | glycoprotein |
| P2Y12 | purinergic signaling |
| cAMP | cyclic adenosine monophosphate |
| VASP-P | phosphorylation-dependent vasodilator-stimulated phosphoprotein |
| PK | protein kinase |
| IR | insulin receptor |
| IGF-1 | insulin-like growth factor 1 |
| Mac-1 | macrophage-1 antigen |
| TF | tissue factor |
| COX | cyclooxygenase |
| TXA | thromboxane |
| HTPR | high on-treatment platelet reactivity |
| ADP | adenosine diphosphate |
| ACS | coronary syndrome |
| MI | myocardial infarction |
| PCI | percutaneous coronary intervention |
| DAT | dual antiplatelet therapy |
| PGI2 | prostacyclin |
| Gi | G-protein inhibitory |